SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease Y Colak, O Ozturk, E Senates, I Tuncer, E Yorulmaz, G Adali, L Doganay, ... Medical science monitor: international medical journal of experimental and …, 2011 | 180 | 2011 |
Red cell distribution width: a novel marker of activity in inflammatory bowel disease A Yeşil, E Şenateş, İV Bayoğlu, ED Erdem, R Demirtunç, AOK Övünç Gut and liver 5 (4), 460, 2011 | 171 | 2011 |
Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 164 | 2022 |
Assessment of endothelial function in patients with nonalcoholic fatty liver disease Y Colak, E Senates, A Yesil, Y Yilmaz, O Ozturk, L Doganay, ... Endocrine 43, 100-107, 2013 | 120 | 2013 |
A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators Y Colak, A Yesil, HH Mutlu, OT Caklili, C Ulasoglu, E Senates, M Takir, ... J Gastrointestin Liver Dis 23 (3), 311-319, 2014 | 103 | 2014 |
Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn's disease compared to healthy control women E Şenateş, Y Çolak, ED Erdem, A Yeşil, E Coşkunpınar, Ö Şahin, ... Journal of Crohn's and Colitis 7 (2), e29-e34, 2013 | 90 | 2013 |
Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls ME Altunöz, E Şenateş, A Yeşil, T Çalhan, AOK Övünç Digestive diseases and sciences 57, 1039-1044, 2012 | 82 | 2012 |
Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease Y Yilmaz, R Kurt, A Gurdal, YO Alahdab, O Yonal, E Senates, N Polat, ... Atherosclerosis 217 (1), 125-129, 2011 | 70 | 2011 |
A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection B Ceylan, B Mete, M Fincanci, T Aslan, Y Akkoyunlu, N Ozguneş, O Colak, ... Wien Klin Wochenschr 125 (15-16), 453-60, 2013 | 62 | 2013 |
Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease E Senates, Y Yilmaz, Y Colak, O Ozturk, ME Altunoz, R Kurt, S Ozkara, ... Metabolic syndrome and related disorders 9 (4), 287-290, 2011 | 61 | 2011 |
Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease Y Colak, CY Karabay, I Tuncer, G Kocabay, A Kalayci, E Senates, ... European journal of gastroenterology & hepatology 24 (6), 613-618, 2012 | 60 | 2012 |
Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease … Y Colak, E Senates, O Ozturk, Y Yilmaz, E Zemheri, FY Enc, C Ulasoglu, ... European journal of gastroenterology & hepatology 24 (3), 255-261, 2012 | 59 | 2012 |
Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome Y Yilmaz, E Senates, T Ayyildiz, Y Colak, I Tuncer, AOK Ovunc, E Dolar, ... European journal of clinical investigation 42 (4), 411-418, 2012 | 58 | 2012 |
Liver, Original Open Access, Ahead of Print Comparison of the Efficacy of Entecavir and Tenofovir in Chronic Hepatitis B F Güzelbulut, AOK Övünç, ZA Çetinkaya, E Şenateş, Y Gökden, ... Hepato-gastroenterology 59, 114, 2012 | 55 | 2012 |
Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease Y Yilmaz, T Ayyildiz, H Akin, Y Colak, O Ozturk, E Senates, I Tuncer, ... Gut and Liver 8 (3), 313, 2014 | 48 | 2014 |
Relationship between neutrophil gelatinase-associated lipocalin (NGAL) levels and inflammatory bowel disease type and activity A Yeşil, C Gönen, E Şenateş, N Paker, Y Gökden, K Koçhan, ED Erdem, ... Digestive diseases and sciences 58, 2587-2593, 2013 | 46 | 2013 |
TLR4 Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease in Comparison to Healthy Controls S Kiziltas, P Ata, Y Colak, B Mesçi, E Senates, F Enc, C Ulasoglu, I Tuncer, ... Metabolic syndrome and related disorders 12 (3), 165-170, 2014 | 45 | 2014 |
Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic … E Şenateş, Y Çolak, A Yeşil, E Coşkunpinar, Ö Şahin, ÖT Kahraman, ... Minerva medica 103 (5), 369, 2012 | 44 | 2012 |
A twin study in Behçet's syndrome S Masatlioglu, E Seyahi, E Tahir Turanli, I Fresko, F Gogus, E Senates, ... Clinical & Experimental Rheumatology 28 (4), S62, 2010 | 44 | 2010 |
Levofloxacin based sequential and triple therapy compared with standard plus probiotic combination for Helicobacter pylori eradication. K Ozdil, T Calhan, A Sahin, E Senates, R Kahraman, B Yüzbasioglu, ... Hepato-gastroenterology 58 (109), 1148-1152, 2011 | 40 | 2011 |